Tekedia Capital congratulates our portfolio company, Revna Biosciences, for hosting representatives from AstraZeneca at RevnaBio campus in Accra, Ghana. The visit, spearheaded by Deepak Arora, Country President – African Cluster, AstraZeneca, was an opportunity for the startup to showcase its world-class capabilities in fostering growth in the fields of precision medicine and molecular diagnostics. Thanks Dr Derrick Edem Akpalu, PhD, MSCR and team for executing the mission.
To learn more about Revnabio, go here. For Tekedia Capital, here.
-From RevnaBio LinkedIn page
Register for Tekedia Mini-MBA edition 19 (Feb 9 – May 2, 2026): big discounts for early bird.
Tekedia AI in Business Masterclass opens registrations.
Join Tekedia Capital Syndicate and co-invest in great global startups.
Register for Tekedia AI Lab: From Technical Design to Deployment (next edition begins Jan 24 2026).
We are delighted to announce that Revna Biosciences recently had the privilege of hosting representatives from AstraZeneca at our facility. The visit, spearheaded by Deepak Arora, Country President – African Cluster, AstraZeneca, was an opportunity to showcase how RevnaBio is addressing unmet needs and fostering growth in the fields of precision medicine and molecular diagnostics.
As a committed research and diagnostics organization, we are enthusiastic about the potential implications of these engagements, both now and in the future. Our team is steadfast in its mission to advance precision medicine in our region, and these interactions signify a substantial stride toward our goal of enhancing health outcomes in Africa.
---
Connect via my
LinkedIn |
Facebook |
X |
TikTok |
Instagram |
YouTube